This inventor holds 1 USPTO granted patent. Top assignees: Smithkline Beecham Corporation, University of Michigan. Active years: 2010.
Company Filing History:
1 out of 2,198 
1 out of 3,519 
Years Active: 2010
Title: Jeffry A Siegal: Innovator in Patient-Specific Dosimetry
Introduction
Jeffry A Siegal is a notable inventor based in Cherry Hill, NJ (US). He has made significant contributions to the field of medical technology, particularly in the area of patient-specific dosimetry. His innovative approach aims to optimize the administration of radiopharmaceuticals for effective disease treatment.
Latest Patents
Jeffry A Siegal holds 1 patent for his invention titled "Patient-specific dosimetry." This patent outlines a method for establishing an optimally effective radiation dose tailored to individual patients. The calculation of the therapeutic dose considers various factors, including the desired total body dose, maximum tolerated dose, typical clearance profile of the radiopharmaceutical, and patient-specific parameters. This method ensures that patients receive a dose that is maximally effective against their disease while minimizing toxicity.
Career Highlights
Throughout his career, Jeffry A Siegal has worked with prestigious institutions, including the University of Michigan and SmithKline Beecham Corporation. His experience in these organizations has contributed to his expertise in the field of radiopharmaceuticals and patient care.
Collaborations
Jeffry has collaborated with notable professionals in his field, including Stewart Kroll and Richard L Wahl. These collaborations have further enhanced his work and contributions to medical technology.
Conclusion
Jeffry A Siegal's innovative work in patient-specific dosimetry represents a significant advancement in the treatment of diseases using radiopharmaceuticals. His dedication to optimizing patient care through tailored therapeutic doses showcases the importance of personalized medicine in modern healthcare.